BALZIVA-28 Overview

Active Ingredient(s):
ETHINYL ESTRADIOL; NORETHINDRONE

Form(s) and Strength(s) Available:

TABLET; ORAL-28: 0.035MG;0.4MG

Details about drugs are organized by FDA Application Number (NDA or ANDA or BLA).

FDA application	Dosage Form	Strength	Marketing Status	Company
NDA #076238	TABLET; ORAL-28	0.035MG;0.4MG	Prescription	BARR

Click on a application number to view drug details

Recall Notices

Celeste Industries Corporation Recalls All Lots of simplySmart Remove Make Up Remover (January 5)
National Brands Inc. Issues a Nationwide Recall of Topaz brand Wafer Rolls Because of Possible Health Risks (December 19)
FDA Announces Class I Recall of Ophthalmic Surgical Device
Stryker Craniomaxillofacial Issues Nationwide Recall of its Custom Cranial Implant Kits; Catalogue Numbers 54-00101, 54-00102, 54-00103 and 54-00104, all lots shipped sterile (December 23)
KRC Food Trading Inc. Recall of Fish Cake Sushi (December 23)

Action Alerts

Alerts do not necessarily reflect the opinion of Medicine.org

Active forum topics

Poll

email this page | older polls | results

Subscribe to our feed

Welcome

Did you know it can take decades for medical innovations to be widely adopted by the healthcare community? To make the best decisions for your health, you need more information than your physician alone can provide. Medicine.org is here to help you become an advocate for your own health by allowing you to share and discover the current healthcare information you need. Learn more.

January 2009

BALZIVA-28 Overview

Sponsored Links

Recall Notices

Action Alerts

Active forum topics

Poll

Subscribe to our feed

Welcome

Diseases & Conditions

Navigation

Resources

Medical Dictionary

Drug Information

Events

Who's online

Job search